Nuwellis NUWE
NASDAQ NUWE
$0.80 +0.01 (+1.52%)
At close: Sep 9, 2026 · 4:00 PM EDT

Nuwellis (NUWE) Income from Continuing Operations (2011 - 2026)

Nuwellis' (NUWE) quarterly Income from Continuing Operations came in at -$4.8 million in Q2 2026, up 61.54% on a YoY basis from -$3.0 million in Q2 2025, and down 6.32% quarter-over-quarter from -$4.5 million in Q1 2026.

Analysis

Nuwellis (NUWE) Income from Continuing Operations (2011 - 2026) Analysis & Trends

Nuwellis (NUWE) has reported Income from Continuing Operations for 16 consecutive years, with -$4.8 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Income from Continuing Operations rose 61.54% year-over-year to -$4.8 million; the trailing twelve-month figure through Jun 2026 stood at -$7.7 million (up 37.99% YoY), and the FY2025 full-year result was -$13.9 million, down 56.69% from the prior year.
  • Income from Continuing Operations slipped to -$4.8 million in Q2 2026 per NUWE's latest filing, from -$4.5 million in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at $2.4 million in Q3 2024 and bottomed at -$12.6 million in Q2 2025.
  • Historically, Income from Continuing Operations has averaged -$3.3 million across 5 years, with a median of -$4.1 million in 2022.
  • The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations jumped 552.21% in 2022, then plunged 214.65% in 2023.
  • Over 5 years, Income from Continuing Operations stood at $1.1 million in 2022, then slumped by 214.65% to -$1.3 million in 2023, then soared by 165.84% to $850000.0 in 2024, then jumped by 45.53% to $1.2 million in 2025, then tumbled by 490.3% to -$4.8 million in 2026.
  • According to Business Quant data, Income from Continuing Operations over the past three periods registered -$4.8 million, -$4.5 million, and $1.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 823.20 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 1.48 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 905.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 241.40 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -92.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 249.10 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 201.00 Mn
10 Nuwellis 140,408.95 -3.78 Mn 1.50 Mn -4.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.83 Mn
Mar 31, 2026 -4.54 Mn
Dec 31, 2025 1.24 Mn
Sep 30, 2025 468,000.00
Jun 30, 2025 -12.55 Mn
Mar 31, 2025 -3.01 Mn
Dec 31, 2024 850,000.00
Sep 30, 2024 2.36 Mn
Jun 30, 2024 -7.73 Mn
Mar 31, 2024 -4.33 Mn
Dec 31, 2023 -1.29 Mn
Sep 30, 2023 -3.37 Mn
Jun 30, 2023 -4.85 Mn
Mar 31, 2023 -6.49 Mn
Dec 31, 2022 1.13 Mn
Sep 30, 2022 -3.87 Mn
Jun 30, 2022 -4.29 Mn
Mar 31, 2022 -4.47 Mn
Dec 31, 2021 -249,000.00
Sep 30, 2021 -5.27 Mn